Foundation Medicine Appoints Troy Cox as CEO

Foundation Medicine, a molecular information company, appointed Troy Cox, as chief executive officer to succeed Michael Pellini, M.D.

Dr. Pellini, who has served as chief executive officer of the company since 2011, has been appointed chairman of the company’s board of directors.

All of these changes will become effective by Feb. 6. Cox joins Foundation Medicine from Roche-Genentech, where he led one of the largest oncology portfolios in the U.S., with more than 1,400 people.

Leave a Comment